Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
H3 Biomedicine
Biotech
The 2022 Biotech Graveyard
Biotech's tumbling market has proven especially perilous, and, for many companies, clinical disappointments were followed by financial dead ends and closures.
Max Bayer
Nov 21, 2022 3:00am
SCOOP: Eisai closing oncology R&D wing H3 Biomedicine
Jul 18, 2022 11:43am
Eisai unit H3 Biomedicine poaches Kura Oncology founder as CMO
Feb 20, 2020 7:55am
Bristol-Myers, H3 Biomedicine explore RNA splicing drugs for cancer
Dec 17, 2018 9:51am
RNA splicing mutations occur in more cancers than we thought
Apr 3, 2018 3:28pm
Chutes & Ladders—Celgene poaches top Merck R&D exec Plenge
May 4, 2017 4:02pm
